Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page displays a 403 Forbidden page, blocking access to the study details content. Users cannot view the trial information as a result.
    Difference
    0.5%
    Check dated 2026-09-26T21:53:28.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden page, replacing the study details with an error screen and a Home button. The page now displays a 403 header and the site footer, indicating the page cannot be accessed.
    Difference
    20%
    Check dated 2026-09-19T19:27:46.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new NIH grant/contract line was added under Other Study ID Numbers. The page revision has been updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:38:05.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Revision: v3.6.5 replaces v3.6.4 in the page, indicating a software version update. This signals a software update and does not alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-08-08T18:17:38.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page's revision tag was updated to Revision: v3.6.4, replacing the previous v3.6.3.
    Difference
    0.1%
    Check dated 2026-07-25T11:41:17.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    Page revision label updated from v3.6.2 to v3.6.3. This indicates a small editorial/technical update to the page, without changing study content or outcomes.
    Difference
    0.1%
    Check dated 2026-07-04T03:47:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.